2026 ICD-10-CM Diagnosis Code T50.4X6AUnderdosing of drugs affecting uric acid metabolism, initial encounter
T50.4X6A is a billable ICD-10-CM diagnosis code for underdosing of drugs affecting uric acid metabolism, initial encounter. The 7th character A marks it as an initial encounter code, used while the patient is receiving active treatment. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). The code is not accepted as a principal diagnosis by the Medicare Code Editor. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Underdosing of drugs and medicaments, initial encounter.
Code Identity
Code Classification
Code EditsBilling
Medicare Code Editor checks that affect claim validity for T50.4X6A.
Coding GuidelinesGuidance
Underdosing refers to taking less of a medication than is prescribed by a provider or a manufacturer's instruction. Codes for underdosing should never be assigned as principal or first-listed codes. If a patient has a relapse or exacerbation of the medical condition for which the drug is prescribed because of the reduction in dose, then the medical condition itself should be coded.
The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of diuretics and other and unspecified drugs, medicaments and biological substances (T50). Use the following options for the applicable episode of care:
- A - initial encounter
- D - subsequent encounter
- S - sequela
Source: ICD-10-CM Official Guidelines for Coding and Reporting, FY 2026, published by CMS and the National Center for Health Statistics.
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Clinical InformationClinical
Allopurinol
a xanthine oxidase inhibitor that decreases uric acid production. it also acts as an antimetabolite on some simpler organisms.Benzbromarone
uricosuric that acts by increasing uric acid clearance. it is used in the treatment of gout.Colchicine
a major alkaloid from colchicum autumnale l. and found also in other colchicum species. its primary therapeutic use is in the treatment of gout, but it has been used also in the therapy of familial mediterranean fever (periodic disease).Probenecid
the prototypical uricosuric agent. it inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.Sulfinpyrazone
a uricosuric drug that is used to reduce the serum urate levels in gout therapy. it lacks anti-inflammatory, analgesic, and diuretic properties.Urate Oxidase
an enzyme that catalyzes the conversion of urate and unidentified products. it is a copper protein. the initial products decompose to form allantoin. ec 1.7.3.3.
Table of Drugs and ChemicalsClinical
Substances in the Table of Drugs and Chemicals that reference this code family. Always confirm in the Tabular List before coding.
Patient EducationClinical
Medication Errors
Medicines treat infectious diseases, prevent problems from chronic diseases, and ease pain. But medicines can also cause harmful reactions if not used correctly. Errors can happen in the hospital, at the health care provider's office, at the pharmacy, or at home. You can help prevent errors by:
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert T50.4X6A to ICD-9-CMHistory
Code HistoryHistory
Questions About T50.4X6AOverview
Is T50.4X6A (Underdosing of drugs affecting uric acid metabolism) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report underdosing of drugs affecting uric acid metabolism, initial encounter on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What does the 7th character A in T50.4X6A mean?
The final character A marks the initial encounter: use it while the patient is receiving active treatment for underdosing of drugs affecting uric acid metabolism, such as an emergency visit or first evaluation.
Can T50.4X6A be a principal diagnosis?
No. The Medicare Code Editor rejects this code as a principal diagnosis because underdosing of drugs affecting uric acid metabolism, initial encounter describes a circumstance that influences health status rather than a current illness. Report it as a secondary diagnosis.
Footnotes
[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.
